Skip to main content

Month: August 2025

Defiance Launches VIXI: Enhanced Long Volatility ETF with Leveraged Short S&P 500 Exposure

Defiance Launches VIXI: Enhanced Long Volatility ETF with Leveraged Short S&P 500 ExposureDefiance ETFs, a pioneer in thematic and leveraged investment solutions, today announced the launch of the Defiance Enhanced Long Vol ETF (VIXI). The Fund seeks enhanced total return by combining approximately 0.75x to 1x long exposure to VIX futures with 1.5x to 2x leveraged short exposure to the S&P 500 Index. Through this dual-strategy approach, VIXI is designed to benefit from periods of heightened volatility and declining equity markets.MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) — Defiance ETFs, a pioneer in thematic and leveraged investment solutions, today announced the launch of the Defiance Enhanced Long Vol ETF (VIXI). The Fund seeks enhanced total return by combining approximately 0.75x to 1x long exposure to VIX futures...

Continue reading

Jyske Realkredit’s auctions for 1 October 2025 refinancing

To Nasdaq Copenhagen A/S                                            8 August 2025 Announcement 64 /2025 Jyske Realkredit’s auctions for 1 October 2025 refinancing        Jyske Realkredit plans to carry out the auctions Tuesday 26th of August through Wednesday 27th of August 2025 for loans in cover pool E. The refinancing amount and bonds to be offered are specified in the table below:  Open Close Alloc. Name ISIN Amount mill. LCRTuesday 26 August 09:30 10:00 10:05 1% 321.E.ok.26 IT1DK00094163803600m 1B               Wednesday 27 August 09:30 10:00 10:05 1% 321.E.ok.26 IT1 26 IT1DK0009416380 3600m 1B               Auction terms appear in the appendix. Questions regarding the bond sale as well as technical matters may be addressed to Jyske Realkredit, Lars Hasløv, Director, Head of mortgage ALM tel. (+45) 89 89 92...

Continue reading

Coloplast A/S – 9M 2024/25 Earnings Release – Invitation to conference call on 19 August 2025 at 11.00am CEST

Tuesday, 19 August 2025 at 11.00 – 12.00h CESTIn connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event. Coloplast will be represented by: Lars Rasmussen – Interim CEOAnders Lonning-Skovgaard – Executive Vice President, CFOAleksandra Dimovska – Vice President, Investor RelationsKristine Husted Munk – Senior Manager, Investor RelationsSimone Dyrby Helvind – Senior Manager, Investor Relations WebcastFor...

Continue reading

Sai Life Sciences Limited Reports Revenue growth of 77% YoY

Q1FY26 Revenue at ₹496 Cr; EBITDA at ₹125 Cr; Net Profit at ₹60 Cr HYDERABAD, India, Aug. 08, 2025 (GLOBE NEWSWIRE) — Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research, Development and Manufacturing Organization (CRDMO) announced its financial results for the first quarter of Fiscal year 2026. Financial Performance:Particulars (₹ crores) Q1FY26 Q1FY25 YoY% FY25 FY24 YoY%Revenue from Operations 496 280 77% 1695 1,465 16%EBITDA 125 31 303% 425 300 42%EBITDA Margin% 25% 11% – 25% 20% –PBT 81 -18 447% 228 109 108%PAT 60 -13 448% 170 83 105%PAT Margin% 12% -5% – 10% 6% –Financial HighlightsRevenue from Operations was ₹496 Cr for Q1FY26 compared to ₹280 Cr in Q1FY25, an increase of 77% driven primarily by strong growth in CDMO segment. EBITDA...

Continue reading

Solar A/S: No. 6 2025 Adjustment of 2025 guidance due to unexpected market slowdown

THIS ANNOUNCEMENT INCLUDES PUBLICATION OF INSIDE INFORMATION. We lower our 2025 revenue guidance to a range of between DKK 11.75bn and 12.25bn (previously DKK 12.3bn to 12.8bn), and our 2025 EBITDA guidance to a range of between DKK 450m and 510m (previously DKK 530m to 600m). CEO Jens Andersen says:“Preliminary figures for Q2 and even more July showed disappointing revenue growth in all key markets. We saw an unexpected market slowdown for Industry and to a lesser extent for Installation. Trade and Climate & Energy delivered growth driven by Solar Polaris’ sales to a major solar park project. We continue to expect a market improvement in 2025, relative to current level. Because of this development, we lower our 2025 revenue guidance to a range of between DKK 11.75bn and 12.25bn and our EBITDA guidance to a range of between...

Continue reading

Sampo plc’s share buybacks 7 August 2025

Sampo plc, stock exchange release, 8 August 2025 at 8:30 am EEST  Sampo plc’s share buybacks 7 August 2025 On 7 August 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                     Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  5,586 9.78 AQEU    113,346 9.80 CEUX  37,609 9.81 TQEX  172,531 9.80 XHELTOTAL 329,072 9.80  * rounded to two decimals                      On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 7 August 2025,...

Continue reading

Nicox Extends Existing Flexible Equity Financing

Press ReleaseNicox Extends Existing Flexible Equity Financing5 million shares added to the existing equity financing line with Vester Finance NCX 470 Denali confirmatory Phase 3 results expected mid-August to mid-September 2025August 08, 2025 – release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced an extension of the PACEO1 equity line of financing entered into with Vester Finance on March 5, 2025, with an additional maximum of 5,000,000 shares (a maximum of 6.43% of the currently issued share capital2 and 4.26% on a fully-diluted basis3). The other terms of the financing, as announced on March 6, 2025, remain unchanged, including the conditions and issue price of the additional shares4. Based on estimated cash and debt...

Continue reading

TGS Awarded Streamer Acquisition Contract

OSLO, Norway (8 August 2025) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of a streamer acquisition contract in the East Mediterranean. Acquisition is scheduled to commence in Q3 this year and the contract has a duration of approximately 30 days. Kristian Johansen, CEO of TGS, commented, “We are very pleased to secure this additional streamer contract. By leveraging the Ramform acquisition platform, coupled with our proprietary GeoStreamer technology we are well equipped to deliver the highest data quality to our client.” For more information, visit TGS.com or contact:  Bård Stenberg IR & Business Intelligence Mobile: +47 992 45 235 investor@tgs.com About TGS TGS provides advanced data and intelligence to companies active in the energy sector. With leading-edge technology...

Continue reading

AVTL to develop new terminal in JNPA, India

AVTL to develop new terminal in JNPA, India Rotterdam, the Netherlands, 8 August 2025 In India, AVTL announced a positive final investment decision to build a greenfield terminal for 132k cbm LPG and 318k cbm liquid products and a LPG bottling plant of 35,000MT capacity in the JNPA port in Mumbai. This is AVTL’s second terminal in the JNPA port which will help grow its market share in servicing a highly industrialized and fast growing hinterland of West and central regions in India. The terminal is expected to be commissioned in phases starting mid 2026. The full investment amount of EUR 170 million, of which the Vopak share is EUR 70 million, will be funded by AVTL. AVTL has recently completed an IPO (link IPO press release). Vopak is a 42.23% shareholder in AVTL. Vopak’s global growth strategy includes industrial and gas...

Continue reading

Regarding the renewal of UAB “Valstybės investicinis kapitalas” EUR 400,000,000 Medium-Term Note Programme guaranteed by the Republic of Lithuania

UAB “Valstybės investicinis kapitalas” (the Issuer) informs that the Issuer’s Management Board by its Decision No. 28 of 5 August 2025 has approved the Issuer’s renewed EUR 400,000,000 medium-term note programme (the Programme). The renewed Programme is intended for investments aimed at strengthening Lithuania’s defence and security industry. Notes issued under the Programme will be guaranteed by the State. In 2025, it is planned to issue notes worth up to EUR 55 million. Luminor Bank AS Lithuanian branch is the arranger of the Programme, responsible for the offering of the notes and their admission to trading on the Nasdaq Vilnius stock exchange. Enclosed: EUR 400,000,000 Medium-Term Note Programme.Contact person: Vaidas DaktariunasValstybės investicinis kapitalas UAB, Chief Executive OfficerPhone: +370 618 29216E-mail: info@vika.lt...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.